The Use of Bivalent Factor H Binding Protein Meningococcal Serogroup B (MenB-fHBP) Vaccine for the Prevention of Meningococcal B Disease

Corporate Authors: National Advisory Committee on Immunization

Publisher: Publisher Public Health Agency of Canada